
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
PR Audio: BROOMFIELD, Colo., June 1, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq:




